REVERSED
1700 Chemical & Materials Engineering
1724 Ex Parte Beers et al 11/010,890 GARRIS 103(a) BACHMAN & LAPOINTE, P.C. c/o CPA Global EXAMINER BERMAN, JASON
2100 Computer Architecture and Software
2111 Ex Parte Barth et al 10/285,931 THOMAS 103(a) MEYERTONS, HOOD, KIVLIN, KOWERT & GOETZEL (AMD) EXAMINER ZAMAN, FAISAL M
2111 Ex Parte Moriwaki et al 10/431,461 HOMERE 102(e)/103(a) OBLON, SPIVAK, MCCLELLAND MAIER & NEUSTADT, L.L.P. EXAMINER DALEY, CHRISTOPHER ANTHONY
2114 Ex Parte Bamford et al 10/831,413 COURTENAY 103(a) HICKMAN PALERMO TRUONG & BECKER/ORACLE EXAMINER TRUONG, LOAN
2166 Ex Parte Christensen et al 10/848,748 SMITH 103(a)/nonstatutory obviousness-type double patenting UNISYS CORPORATION EXAMINER PHAM, KHANH B
A claim limitation is presumed to invoke § 112, ¶6 when it explicitly uses the phrase “means for” or “step for” and includes functional language. That presumption is overcome when the limitation further includes the structure necessary to perform the recited function. See U.S. Patent & Trademark Office, Supplementary Examination Guidelines for Determining Compliance With 35 U.S.C. 112 and for Treatment of Related Issues in Patent Applications, Part 1, § III.C.3, 76 Fed. Reg. 7162, 7167 (Feb. 9, 2011). If the claim limitation invokes § 112, ¶ 6, the claim limitation must be construed to cover the corresponding structure, material, or acts described in the specification and equivalents thereof. Id. at 7164.
2165 Ex Parte Hu et al 10/982,135 HOMERE 101/102(b) 37 C.F.R. § 41.50(b) 102(b) HICKMAN PALERMO TRUONG & BECKER/ORACLE EXAMINER SYED, FARHAN M
2173 Ex Parte Chapman 10/751,616 THOMAS 103(a) SCHMEISER, OLSEN & WATTS EXAMINER ULRICH, NICHOLAS S
3700 Mechanical Engineering, Manufacturing, and Products & Design
3733 Ex Parte Lindemann et al 11/520,946 LEE 103(a) Medtronic, Inc (Spinal/Krieg DeVault) EXAMINER COTRONEO, STEVEN J
AFFIRMED-IN-PART
2100 Computer Architecture and Software
2161 Ex Parte Alperin 11/399,584 HOMERE 102(b) 102(b) 37 C.F.R. § 41.50(b) 103(a) Qwest Communications International Inc. EXAMINER PADMANABHAN, KAVITA
AFFIRMED
1600 Biotechnology and Organic Chemistry
1627 Ex Parte Roscher et al 10/589,871 BONILLA 103(a) NATH & ASSOCIATES PLLC EXAMINER CHONG, YONG SOO
3700 Mechanical Engineering, Manufacturing, and Products & Design
3748 Ex Parte Tabata et al 10/713,355 SPAHN 103(a) FOLEY AND LARDNER LLP EXAMINER TRAN, DIEM T
NEW
REVERSED
Ex Parte Bohn et al
10/350,144 ZECHER 103(a)
1782 Ex Parte Dawes10/381,897 HANLON 103(a) RATNERPRESTIA EXAMINER PATTERSON, MARC A
3622 Ex Parte Graves et al11/303,258 MOHANTY 103(a) LANDMARK INTELLECTUAL PROPERTY LAW, PLLC EXAMINER VAN BRAMER, JOHN W
2166 Ex Parte Kress et al10/848,668 SMITH 102(e)/103(a) UNISYS CORPORATION EXAMINER PHAM, KHANH B
Ex Parte Kuecuek et al
11/658,062 HASTINGS 112(2)/102(b)/103(a)
Ex Parte Lee
10/976,384 CHEN 103(a)
AFFIRMED-IN-PART
Ex Parte Gulbenkian
10/370,634 GRIMES 103(a)
AFFIRMED
Ex Parte McConnell et al
09/832,718 MOHANTY 103(a)
Ex Parte Nelson
10/906,651 DESHPANDE 112(1)/103(a)
1788 Ex Parte O'Hara et al 10/987,131 GARRIS 112(1)/103(a) General Motors Corporation c/o REISING ETHINGTON P.C. EXAMINER DESAI, ANISH P
